Quantum Leap, which has been around for over 27 years now, offers two new recommendations each month on the hottest growth shares – plus updates on earlier tips and the latest thoughts of veteran investor and renowned stock picker Quentin Lumsden.

You can trial Quantum Leap free for 30 days, with full access to the online archive, including the latest newsletter and Quentin’s 14 nap selections for 2012.  If you decide during this time that Quantum Leap is not for you, you're welcome to cancel and we won't charge you a thing!

To sign up for a free 30 day trial, please enter your details below.

  1. Please enter a valid phone number as we may need to ring you to activate your account.
  2. Please create a password to be used to access content on the Quantum Leap website.
    This needs to be at least 6 characters long.

  3. Would you like to receive a hard copy of Quantum Leap each month?

    Yes No
  4. Would you also like to receive free weekly e-mails on the market outlook in The Share Weekly?

    Yes No
  5. If you have any trouble signing up or any questions about Quantum Leap, please call us on 020 7502 8220 or e-mail subscriptions@quantumleapnewsletter.co.uk.

View our Privacy Policy

Risk Warning

The tips given on Quantum Leap are of necessity, general. They cannot relate to the individual circumstances of investors. Anyone considering following the recommendations on the site should seek independent advice from a stockbroker or financial adviser authorised by the Financial Services Authority. So, while we would not wish to reduce our liability under the FSA regulatory regime, we cannot otherwise be held liable if individuals suffer losses through following tips contained on this site. The value of investments can go down as well as up. The past is not necessarily a guide to future performance. Investing in equities can lose you part or all of your capital. Profits from dealing in shares may be liable to tax. The level of tax and bases of relief from tax are subject to change. Changes in the rates of exchange may have an adverse effect on the value or price of an investment in sterling terms if it is denominated in a foreign currency.